Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

HealthEquity Inc. (HQY)

NASDAQ: HQY · Services-Business Services, NEC · Draper, UT

Our rating: Positive

Positive reaffirmed at $96.37, moderate conviction, August 28, 2026.

Breaks if: The Positive call breaks down if revenue growth decelerates to below 5% on a trailing twelve-month basis in any reported quarter over the next four quarters, or if FCF margin falls below 28% for two consecutive reported periods — either would unwind the core growth-plus-cash-conversion argument that justifies the current multiple. On the price side, a drawdown of 20% from today within twelve months, absent a broad market dislocation, would signal that near-term fundamental weakness is surfacing in reported results ahead of what the annual figures currently show.

Key figures

Market value$7.8B
Revenue, last 12 months$1.4B
Net income, last 12 months$236M
Free cash flow, last 12 months$488M
Price to earnings33.1×
Free cash flow yield6.2%
Dividend yield0.0%
Operating margin25.8%
Return on equity11.4%
Beta to the S&P 5000.86
Volatility, annualized37.8%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
July 31, 2026$351M7.6%$0.78$135M
April 30, 2026$355M7.2%$0.82$97M
January 31, 2026$335M7.3%$0.58$118M
October 31, 2025$322M7.2%$0.59$138M
July 31, 2025$326M8.6%$0.68$135M
April 30, 2025$331M15.0%$0.61$65M
January 31, 2025$312M18.8%$0.30$75M
October 31, 2024$300M20.5%$0.06$90M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

7 ledger entries and 61 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.